True North Advisors, LLC Amgen Inc Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, True North Advisors, LLC holds 1,130 shares of AMGN stock, worth $327,587. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,130

Previous 910 24.18%

Holding current value

$327,587

Previous $284,000 28.17%

% of portfolio

0.1%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $68,063 - $74,223	220 Added 24.18%	1,130 $364,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $1,344 - $1,622	-5 Reduced 0.55%	910 $258,000
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $1,278 - $1,442	5 Added 0.55%	915 $263,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $31,648 - $35,694	-141 Reduced 13.42%	910 $205,000
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $31,376 - $34,916	136 Added 14.86%	1,051 $255,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $234,180 - $259,064	-1,068 Reduced 53.86%	915 $221,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $40,969 - $46,885	-206 Reduced 9.41%	1,983 $446,000
Q3 2021 Jun 07, 2022	BUY	$212.27 - $248.7 $231,374 - $271,083	1,090 Added 99.18%	2,189 $465,000
Q2 2021 Jun 07, 2022	SELL	$233.58 - $259.14 $25,226 - $27,987	-108 Reduced 8.95%	1,099 $267,000
Q1 2021 Jun 07, 2022	BUY	$221.91 - $258.6 $44,382 - $51,720	200 Added 19.86%	1,207 $300,000
Q4 2020 May 20, 2022	BUY	$216.38 - $257.67 $34,620 - $41,227	160 Added 18.89%	1,007 $231,000
Q3 2020 May 20, 2022	BUY	$234.65 - $260.95 $198,748 - $221,024	847 New	847 $215,000
Q1 2020 May 12, 2022	SELL	$182.24 - $241.7 $161,829 - $214,629	-888 Closed	0 $0
Q4 2019 May 12, 2022	BUY	$189.21 - $243.2 $168,018 - $215,961	888 New	888 $214,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Amgen Inc Transaction History